Allurion Technologies (ALUR) Competitors $2.37 -0.20 (-7.62%) Closing price 03:59 PM EasternExtended Trading$2.39 +0.02 (+1.06%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALUR vs. MBOT, GUTS, HYPR, SURG, ICAD, APT, TMDIF, ECOR, TELA, and APYXShould you be buying Allurion Technologies stock or one of its competitors? The main competitors of Allurion Technologies include Microbot Medical (MBOT), Fractyl Health (GUTS), Hyperfine (HYPR), SurgePays (SURG), iCAD (ICAD), Alpha Pro Tech (APT), Titan Medical (TMDIF), electroCore (ECOR), TELA Bio (TELA), and Apyx Medical (APYX). These companies are all part of the "medical equipment" industry. Allurion Technologies vs. Microbot Medical Fractyl Health Hyperfine SurgePays iCAD Alpha Pro Tech Titan Medical electroCore TELA Bio Apyx Medical Microbot Medical (NASDAQ:MBOT) and Allurion Technologies (NYSE:ALUR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, community ranking, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk. Does the media prefer MBOT or ALUR? In the previous week, Microbot Medical had 13 more articles in the media than Allurion Technologies. MarketBeat recorded 14 mentions for Microbot Medical and 1 mentions for Allurion Technologies. Microbot Medical's average media sentiment score of 0.55 beat Allurion Technologies' score of -1.00 indicating that Microbot Medical is being referred to more favorably in the media. Company Overall Sentiment Microbot Medical Positive Allurion Technologies Negative Which has higher valuation and earnings, MBOT or ALUR? Microbot Medical has higher earnings, but lower revenue than Allurion Technologies. Microbot Medical is trading at a lower price-to-earnings ratio than Allurion Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMicrobot MedicalN/AN/A-$10.74M-$0.74-3.45Allurion Technologies$32.11M0.37-$80.61M-$9.95-0.25 Do analysts prefer MBOT or ALUR? Microbot Medical currently has a consensus price target of $9.00, indicating a potential upside of 252.94%. Allurion Technologies has a consensus price target of $22.83, indicating a potential upside of 813.33%. Given Allurion Technologies' higher possible upside, analysts clearly believe Allurion Technologies is more favorable than Microbot Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Microbot Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Allurion Technologies 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is MBOT or ALUR more profitable? Microbot Medical has a net margin of 0.00% compared to Allurion Technologies' net margin of -71.24%. Allurion Technologies' return on equity of 0.00% beat Microbot Medical's return on equity.Company Net Margins Return on Equity Return on Assets Microbot MedicalN/A -218.30% -158.17% Allurion Technologies -71.24%N/A -56.75% Do insiders and institutionals have more ownership in MBOT or ALUR? 16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 21.4% of Allurion Technologies shares are held by institutional investors. 5.4% of Microbot Medical shares are held by company insiders. Comparatively, 22.4% of Allurion Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, MBOT or ALUR? Microbot Medical has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Allurion Technologies has a beta of -0.61, meaning that its share price is 161% less volatile than the S&P 500. Does the MarketBeat Community prefer MBOT or ALUR? Microbot Medical received 341 more outperform votes than Allurion Technologies when rated by MarketBeat users. However, 72.73% of users gave Allurion Technologies an outperform vote while only 70.79% of users gave Microbot Medical an outperform vote. CompanyUnderperformOutperformMicrobot MedicalOutperform Votes34970.79% Underperform Votes14429.21% Allurion TechnologiesOutperform Votes872.73% Underperform Votes327.27% SummaryAllurion Technologies beats Microbot Medical on 10 of the 17 factors compared between the two stocks. Remove Ads Get Allurion Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ALUR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALUR vs. The Competition Export to ExcelMetricAllurion TechnologiesSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$11.99M$4.08B$5.34B$18.62BDividend YieldN/A39.50%5.11%4.24%P/E Ratio-0.2127.6121.7631.24Price / Sales0.3747.60378.0625.86Price / CashN/A51.0838.1517.54Price / Book-0.075.816.414.31Net Income-$80.61M$67.09M$3.20B$1.02B7 Day Performance0.20%6.23%6.59%6.92%1 Month Performance4.17%-3.18%-8.57%-6.59%1 Year Performance-95.82%14.76%10.11%1.58% Allurion Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALURAllurion Technologies2.2656 of 5 stars$2.37-7.6%$22.83+865.5%-95.7%$11.34M$32.11M-0.20501Short Interest ↑Negative NewsMBOTMicrobot Medical1.7594 of 5 stars$1.51+1.3%$9.00+496.0%+125.7%$52.46MN/A-1.8920Analyst RevisionGap DownGUTSFractyl Health1.9159 of 5 stars$1.07-4.5%$10.00+834.6%-84.7%$52.34M$93,000.00-0.09102Analyst ForecastGap UpHigh Trading VolumeHYPRHyperfine3.0125 of 5 stars$0.65-1.5%$1.33+104.6%-26.0%$50.61M$12.89M-1.14190Short Interest ↑Gap DownSURGSurgePays2.3192 of 5 stars$2.34+0.4%$8.50+263.2%-37.6%$47.76M$60.88M-2.0740ICADiCAD0.3178 of 5 stars$1.71-2.3%N/A+7.7%$46.80M$19.61M-13.15140Short Interest ↑APTAlpha Pro TechN/A$4.30-1.8%N/A-28.7%$46.75M$57.84M11.62120Analyst ForecastTMDIFTitan MedicalN/A$0.37-5.5%N/A+715.6%$41.76M$17.63M-0.2950Gap DownECORelectroCore3.4654 of 5 stars$5.68+0.4%$25.50+348.9%+2.4%$40.86M$25.18M-3.1050Gap DownTELATELA Bio2.1759 of 5 stars$0.98-9.3%$7.25+639.8%-79.5%$38.60M$69.30M-0.58120Short Interest ↑APYXApyx Medical2.0431 of 5 stars$1.00+1.0%N/A-26.7%$37.79M$48.10M-1.20270 Remove Ads Related Companies and Tools Related Companies Microbot Medical Competitors Fractyl Health Competitors Hyperfine Competitors SurgePays Competitors iCAD Competitors Alpha Pro Tech Competitors Titan Medical Competitors electroCore Competitors TELA Bio Competitors Apyx Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ALUR) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allurion Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allurion Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALUR Stock Free ALUR Stock Alerts